Armata Pharmaceuticals, Inc. (ARMP)
NYSE
3.86
+0.05 (+1.31%)
Closed
Oct 8, 2026
Day's Range
3.603.91
52 wk Range
3.0916.34
Financial Statements - ARMP - Armata Pharmaceuticals, Inc.
Revenue
0
Net Income
-173.79M▼ 818.8%
EBITDA
-150.26M▼ 1566.8%
Free Cash Flow
-26.30M▲ 33.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -31.22M | -42.43M | -40.89M | -36.94M | -23.82M | -21.58M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -126.37M | 33.56M | -25.70M | - | 726K | 6K |
| Pre Tax Income | -173.79M | -18.91M | -69.04M | -36.91M | -23.15M | -22.18M |
| Income Tax | - | - | - | - | - | - |
| Net Income | -173.79M | -18.91M | -69.04M | -36.91M | -23.15M | -22.18M |
| EPS Basic | -4.8 | -0.52 | -1.91 | -1.08 | -0.96 | -1.35 |
| EPS Diluted | -4.8 | -0.89 | -1.91 | -1.08 | -0.96 | -1.35 |
| Basic Shares Outstanding | 36.23M | 36.16M | 36.07M | 34.29M | 24.10M | 16.41M |
| Diluted Shares Outstanding | 36.23M | 36.16M | 36.07M | 34.29M | 24.10M | 16.41M |
| Ebit | -157.20M | -8.17M | -66.41M | -36.91M | -23.09M | -21.55M |
| Ebitda | -150.26M | -9.01M | -61.58M | -36.02M | -22.64M | -20.43M |
| Net Income Continuous Operations | -173.79M | -18.91M | -69.04M | -36.91M | -23.15M | -22.18M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
